Personalized Pathways: Redefining Frontline Hodgkin Lymphoma Treatment Strategies

In this episode, Jonathan W. Friedberg, MD; Alex F. Herrera, MD; and Kara Kelly, MD, discuss the latest frontline treatment options for advanced Hodgkin lymphoma (HL) and approaches to personalizing treatment for the general patient population, older patients, and pediatric patients. This podcast was adapted from a live presentation held in May 2025.

• The Landscape of Frontline Options in HL
• Special Considerations for Older Patients
• Special Considerations for Pediatric Patients
• Future Directions in HL

Presenters:

Jonathan W. Friedberg, MD
Director, Wilmot Cancer Institute
Samuel Durand Professor of Medicine and Oncology
University of Rochester
Rochester, New York

Alex F. Herrera, MD
Chief, Division of Lymphoma
Professor, Department of Hematology and Hematopoietic Cell Transplantation
Medical Director of the City of Hope Clinical Trials Office
Associate Medical Director of the Briskin Center for Clinical Research
City of Hope Medical Center
Duarte, California

Kara M. Kelly, MD
Waldemar J. Kaminski Endowed Chair of Pediatrics
Roswell Park Comprehensive Cancer Center
Division Chief and Professor of Pediatrics
University at Buffalo Jacobs School of Medicine and Biomedical Sciences
Buffalo, New York

Content based on an online CME program supported by an independent educational grant from Bristol Myers Squibb.

Link to CME: Claim Credit
https://bit.ly/3TQ0M45

Link to full program: 
https://bit.ly/4eV8AuW

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.